2.49000 EUR
0.045
1.78%
Last update Dec 16, 7:32 PM CET
Main market
Day range
2.49000
2.54500
Previous close
2.53500
Open
2.54500
Access this stock data via API
Subscribe
BioInvent International AB
2.49
0.05
1.78%

Financials

Income statement

Fundamentals currency is SEK
Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 18.2M 2.0M 2.0M 1.2M
Cost of revenue
Gross profit
Operating expense
Research & development 13.3M 11.7M 11.9M 9.9M
Selling general and admin 1.7M 1.6M 1.6M 1.2M
Other operating expenses 83.6K -39.4K 23.1K -34.5K
Operating income 3.1M -11.3M -11.6M -9.9M
Non operating interest income
Income
Expense
Other income expense
Pretax income 3.6M -10.7M -10.7M -8.9M
Tax provision 9.4K 3.4K 4.4K 2.6K
Net income 3.6M -10.7M -10.7M -8.9M
Basic EPS 0.6 -1.8 -1.8 -1.5
Diluted EPS 0.6 -1.8 -1.8 -1.5
Basic average shares 6.0M 6.1M 6.0M 6.0M
Diluted average shares 6.0M 6.1M 6.0M 6.0M
EBITDA 3.2M -11.4M -12.0M -10.3M
Net income from continuing op. 3.1M -11.3M -11.6M -9.8M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 30 minutes

09:29
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).